BHC
Bausch Health Companies Inc
NYSE: BHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.59
-1.41% today
Updated 2026-04-29
Market cap
$2.09B
P/E ratio
13.31
P/S ratio
0.20x
EPS (TTM)
$0.42
Dividend yield
—
52W range
$4 – $9
Volume
1.9M
WallStSmart proprietary scores
70
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+5.5
Quality
C+7.5
Profitability
B+7.7
Valuation
B+4/9
Piotroski F-Score
Moderate
0.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$7.57
+35.42%
12-Month target
$5.67
+1.43%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy0 Buy8 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 43.60% — strong efficiency
+ Free cash flow $402.53M — positive
+ Debt/equity -38.28x — low leverage
Risks
- Altman Z 0.21 — distress zone
- Thin margins at 1.53%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $8.12B | $8.76B | $9.63B | $10.31B | $10.27B |
| Net income | $-225.00M | $-592.00M | $-46.00M | $155.28M | $-113.72M |
| EPS | — | — | — | — | $0.42 |
| Free cash flow | $-996.00M | $760.00M | $1.26B | $1.00B | $402.53M |
| Profit margin | -2.77% | -6.76% | -0.48% | 1.51% | 1.53% |
Peer comparison
Smart narrative
Bausch Health Companies Inc trades at $5.59. representing a P/E of 13.31x trailing earnings. Our Smart Value Score of 70/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.21, it sits in the distress. TTM revenue stands at $10.27B. with profit margins at 1.53%.
Frequently asked questions
What is Bausch Health Companies Inc's stock price?
Bausch Health Companies Inc (BHC) trades at $5.59.
Is Bausch Health Companies Inc overvalued?
Smart Value Score 70/100 (Grade B, Buy).
What is the price target of Bausch Health Companies Inc (BHC)?
The analyst target price is $7.57, representing +35.4% upside from the current price of $5.59.
What is Bausch Health Companies Inc's revenue?
TTM revenue is $10.27B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
0.21 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.20x
ROE43.60%
Beta0.40
50D MA$5.52
200D MA$6.38
Shares out0.37B
Float0.26B
Short ratio—
Avg volume1.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—